Paxlovid: UK medicines regulator approves second Covid antiviral pill
Paxlovid can cut the risk of hospitalisation in vulnerable adults by 89%, a clinical trial suggests.Paxlovid can cut the risk of hospitalisation in vulnerable adults by 89%, a clinical trial suggests.